Clinical Trial Update: Immunological Basis for Mepolizumab Activity in COPD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring the immunological basis for mepolizumab activity in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Temple University | Conditions: COPD | Phase 2 | Status: UNKNOWN